Indian firm gets nod to sell pain relieving tablets in US
Indian drug maker Shasun Pharmaceuticals on Monday said that it has got the approval from United States Food & Drug Administration (USFDA) for selling its pain relieving tablets in the US market.
The approval has come for carisoprodol tablets with 250 mg and 350mg strength. The drug has estimated market size of $38 million.
“Carisoprodol tablets 250 mg and 350 mg have sales of approximately $38 million. While the 350 mg has a few generic players, Shasun expects to be the first marketed generic player in the $16 million Carisoprodol tablets of 250 mg opportunity,” the company said in a statement.
The product will be manufactured at Shasun’s Puducherry plant and distributed through a partner, it said, adding that the drug is to be launched in the market shortly.
Carisoprodol is used for blocking pain sensations between nerves and the brain. The Chennai-based company also has offices in the US and UK.
November 16, 2015 |2:41pm IST
The facilities will provide refrigerated container plug-in facilities for cold warehousing..
Read more
The imposition tariffs by Beijing are in response to the 25% on duty on steel and 10% on ..
Read more
The Government has permitted exports of white sugar until September 2018 under DFIA scheme..
Read more
to success.